Endeavor

FDA Approves New Approach to Stem Cell Transplants

Roxanne Laveau’s participation in a clinical trial helped lead to the FDA approval of the Orca-T cell therapy for transplant in patients with blood cancers

Patient Meets Donor on Three-Year Anniversary of Transplant

Lloyd Hyatt has been cancer-free thanks to a stranger from Germany

New Treatment Approach Could Redefine Standard Chemotherapy for Acute Myeloid Leukemia

Study finds azacitidine and venetoclax may match or outperform standard chemotherapy for newly diagnosed patients

Using Machine Learning To Predict Response in Acute Myeloid Leukemia

Probabilities shown in real time can inform better decision-making

10,000th Bone Marrow Transplant Gives Sarasota Man a Second Chance

Patient’s journey highlights the teamwork and innovation behind Moffitt Cancer Center’s 10,000th transplant

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

Immunotherapy May Help Prevent Acute Myeloid Leukemia Relapse After Transplant

Early phase 1 trial results indicate safety and efficacy of donor gamma delta T cell infusions

New Study Suggests Socioeconomic Status Affects Access to Leukemia Transplant, Not Survival

Researchers point to access to care as a major issue for people in lower socioeconomic brackets

Moffitt Researchers Find Breakthrough Treatment for Aggressive Blood Cancers

Promising combo therapy and innovative tracking techniques offer new hope for patients